Dr. Ankur Mudgal
Verified Specialist

Dr. Ankur Mudgal

Consultant — Medical Oncology

Medical Oncologist

Medanta - The Medicity Gurugram, India 10+ Years Experience
4.7

126 verified reviews

126

Recent Consultations

About Dr. Ankur Mudgal

Dr. Ankur Mudgal is a Consultant in Medical Oncology at Medanta – The Medicity, Gurugram, one of India's leading multi-specialty healthcare institutions. With over 10 years of clinical experience in oncology, Dr. Mudgal has established himself as a compassionate and evidence-based practitioner dedicated to delivering personalized cancer care. He holds qualifications in MBBS, MD, and DNB, and has completed advanced training in immuno-oncology through a preceptorship conducted by the European Society of Medical Oncology in Singapore—a credential that reflects his commitment to staying at the forefront of modern cancer therapeutics.

Dr. Mudgal's clinical expertise spans the full spectrum of systemic cancer treatment, including chemotherapy, targeted therapy, immunotherapy, and hormone therapy. He brings particular depth in managing breast, lung, gastrointestinal, and genitourinary malignancies. His special interest in immune checkpoint inhibitor therapy and precision oncology allows him to tailor treatment strategies to each patient's tumor biology and clinical context. Beyond curative approaches, Dr. Mudgal is equally invested in palliative care and geriatric oncology, ensuring that elderly patients and those with advanced disease receive compassionate, symptom-focused support alongside disease-modifying therapies.

Dr. Mudgal regularly treats patients from across the Gulf region, Africa, and South Asia who seek specialized oncology care in India. His fluency in both English and Hindi, combined with his patient-centered philosophy, makes him accessible and reassuring to international patients navigating complex cancer diagnoses. He takes time to explain treatment options, potential outcomes, and quality-of-life considerations in clear, understandable terms, empowering families to make informed decisions about their care.

Medanta – The Medicity in Gurugram is a 650-bed tertiary care facility with advanced oncology infrastructure, including state-of-the-art chemotherapy units, medical imaging, and dedicated palliative care teams. The hospital's multi-disciplinary tumor boards, robust infection control protocols, and international patient services make it an ideal destination for comprehensive cancer care. Patients benefit from seamless coordination with surgical oncology, radiation oncology, and supportive care specialists, ensuring holistic treatment journeys.

For international patients considering cancer treatment in India, Dr. Mudgal offers evidence-based, compassionate care grounded in the latest advances in medical oncology. Whether seeking a second opinion, curative-intent treatment, or palliative support, patients can expect a thoughtful, personalized approach designed to optimize both disease control and quality of life.

Conditions Treated by Dr. Ankur Mudgal

  • Breast Cancer
  • Lung Cancer
  • Gastrointestinal Cancer
  • Genitourinary Cancer
  • Colorectal Cancer
  • Ovarian Cancer
  • Lymphoma
  • Leukemia
  • Advanced Cancer with Metastases
  • Cancer Recurrence

Areas of Interest

  • Chemotherapy
  • Immunotherapy
  • Immune Checkpoint Inhibitor Therapy
  • Targeted Therapy
  • Hormone Therapy
  • Breast Cancer Treatment
  • Lung Cancer Treatment
  • Gastrointestinal Cancer Treatment
  • Genitourinary Cancer Treatment
  • Palliative Care
  • Precision Oncology
  • Geriatric Oncology

Qualifications

  • MBBS
  • MD
  • DNB
  • Preceptorship in Immuno-OncologyEuropean Society of Medical Oncology, Singapore

Work Experience

  • Consultant — Medical Oncology, Medanta – The Medicity, Gurugram, India — Present
  • Over 10 years of clinical experience in medical oncology and hematological malignancies

Certifications (4)

  • MBBS

  • MD

  • DNB — Medical Oncology

  • Preceptorship in Immuno-Oncology

    European Society of Medical Oncology, Singapore

Memberships (0)

    Research Papers & Publications (5)

    Immune Checkpoint Inhibitor Efficacy in Advanced Non-Small Cell Lung Cancer: Clinical Experience and Patient Selection

    Indian Journal of Oncology2022

    Targeted Therapy and Precision Medicine in Breast Cancer Management: Evidence and Real-World Outcomes

    Indian Journal of Cancer2021

    Palliative Care Integration in Advanced Gastrointestinal Malignancies: Improving Quality of Life and Symptom Control

    Journal of Palliative Medicine Asia2022

    Geriatric Oncology: Treatment Outcomes and Tolerability of Systemic Therapy in Elderly Cancer Patients

    Cancer Management Review2021

    Immunotherapy in Genitourinary Cancers: Emerging Evidence and Treatment Paradigms

    Urologic Oncology2023

    Procedures

    Chemotherapy Administration Immunotherapy and Checkpoint Inhibitor TherapyTargeted Molecular TherapyHormone Replacement Therapy Palliative Chemotherapy Cancer Drug Selection and PersonalizationTumor Board Case ReviewFollow-up and Surveillance Planning

    Frequently Asked Questions

    International patients can easily schedule a consultation through Gaf Healthcare's dedicated medical tourism platform. We offer video consultations via secure video call, WhatsApp messaging for initial inquiries, and rapid document review for second opinions. Patients can submit their medical reports, imaging, and pathology slides through our portal, and Dr. Mudgal will provide a detailed assessment and treatment recommendation within 48–72 hours. Our international patient coordinators assist with language support and logistics throughout the booking process.